Alberto Ribo Mas's most recent trade in Becton, Dickinson And Co. was a trade of 15,121 Stock Appreciation Rights done . Disclosure was reported to the exchange on Nov. 26, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Becton, Dickinson And Co. | Alberto Ribo Mas | EVP and Pres, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 15,121 | 15,121 | - | - | Stock Appreciation Rights | |
Becton, Dickinson And Co. | Alberto Ribo Mas | EVP and Pres, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 2,116 | 11,662 (0%) | 0% | 0 | Common Stock | |
Becton, Dickinson And Co. | Alberto Ribo Mas | EVP and Pres, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 1,686 | 10,344 (0%) | 0% | 0 | Common Stock | |
Becton, Dickinson And Co. | Alberto Ribo Mas | EVP and Pres, Life Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2021 | 798 | 9,546 (0%) | 0% | 0 | Common Stock | |
Becton, Dickinson And Co. | Alberto Ribo Mas | EVP and Pres, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 21,694 | 21,694 | - | - | Stock Appreciation Rights | |
Becton, Dickinson And Co. | Alberto Ribo Mas | EVP and Pres, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 5,893 | 5,893 | - | - | Stock Appreciation Rights | |
Becton, Dickinson And Co. | Alberto Ribo Mas | EVP and Pres, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 949 | 9,330 (0%) | 0% | 0 | Common Stock | |
Becton, Dickinson And Co. | Alberto Ribo Mas | EVP and Pres, Life Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2020 | 672 | 8,658 (0%) | 0% | 0 | Common Stock |